{"success":true,"data":{"pressRelease":{"id":"136129","rtpr_id":"nGNXbyq9YR-20260904","ticker":"NNOX","exchange":"NASDAQ","all_tickers":["NNOX"],"title":"Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England","author":"Globe Newswire","published_at":"2026-09-04T12:45:58.302Z","article_body":"Expands Nanox’s growing U.S. distribution network with a leading New\nEngland-based medical imaging provider\n\nPETACH TIKVA, Israel — September 4 2026 — Nano-X Imaging Ltd.\n(https://www.globenewswire.com/Tracker?data=D6dzEXnyZ1mc9pKURbmOrl5IbsuTD_iVXQnwi9y_NOl6DN3ic3vkP4dG0aqCF6CsZKl8CVGM1gm7z_Og7PMs_BHAXfWDJy0THVsHXRmWXBI=)\n(“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in innovative\nmedical imaging technology, today announced that its U.S.-based subsidiary,\nNanox Impact Inc., has entered into a distribution agreement with Associated\nX-Ray Imaging Corp., a New England-based provider of medical imaging equipment\nand services, specializing in X-ray, MRI, and CT systems, to support\ndeployment of the Nanox.ARC across the region.\n\nUnder the agreement, Associated X-Ray Imaging will market, distribute, and\nsupport the Nanox.ARC, an FDA-cleared, multisource 3D digital tomosynthesis\nsystem, leveraging its established regional presence and service\ninfrastructure across New England. The collaboration is expected to support\nNanox’s ongoing U.S. commercial execution by expanding access to advanced 3D\nimaging within additional outpatient and community-based clinical settings.\n\nAssociated X-Ray Imaging has been serving healthcare providers across New\nEngland for decades, supplying and servicing a broad range of diagnostic\nimaging technologies for hospitals, imaging centers, and specialty clinics.\n\n“We continue to build our U.S. commercial footprint through focused regional\ndistribution partnerships that are aligned with our deployment strategy,”\nsaid Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox.\n“Associated X-Ray Imaging brings long-standing customer relationships,\nstrong technical expertise, and a deep understanding of the New England\nimaging market. This partnership supports our efforts to expand measured\nadoption of the Nanox.ARC across additional clinical environments.”\n\n“We are pleased to partner with Nanox and add the Nanox.ARC to our imaging\nportfolio,” said John Olenio, Owner, Founder and Chief Executive Officer of\nAssociated X-Ray Imaging Corp. “We believe the Nanox.ARC offers a compelling\napproach to 3D imaging that aligns with our focus on providing practical\ndiagnostic solutions supported by reliable service across New England.”\n\nThis agreement represents another step in Nanox’s U.S. channel partner\nstrategy, as the Company continues to expand a diversified distribution\nnetwork to support commercial deployment of the Nanox.ARC across targeted U.S.\nregions.\n\nAbout Associated X-Ray Imaging Corp\n\nFounded in 1975, Associated X-Ray Imaging Corp. is a New England-based\nprovider of medical imaging equipment, service, and supplies. The company\nsupports hospitals, imaging centers, and specialty clinics with diagnostic\nimaging technologies across multiple modalities, including X-ray, MRI, and CT,\nsupported by a regional sales and service organization. For more information,\nvisit www.associatedxray.com\n\nAbout Nanox\n\nNanox (NASDAQ: NNOX) is focused on driving the world’s transition to\npreventive health care by delivering an integrated, end-to-end medical imaging\nand healthcare services platform.\n\nNanox combines affordable imaging hardware, advanced AI-based solutions,\ncloud-based software, access to remote radiology, health IT solutions, and a\nmarketplace to enable earlier detection, improved clinical efficiency, and\nbroader access to care.\n\nNanox’s vision is to expand the reach of medical imaging both within and\nbeyond traditional hospital settings by providing a seamless solution from\nscan to interpretation and beyond. By leveraging proprietary digital X-ray\ntechnology, AI-driven analytics, and a clinically driven approach, Nanox aims\nto enhance the efficiency of routine imaging workflows, support early\ndetection of disease, and improve patient outcomes.\n\nThe Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source\ndigital tomosynthesis imaging system designed for ease of use and\nscalability; Nanox.AI, a suite of AI-based algorithms that augment the\ninterpretation of routine CT imaging to identify early signs often associated\nwith chronic disease; Nanox.CLOUD, a cloud-based platform for secure data\nmanagement, storage, and advanced\nimaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide\naccess to remote radiology and cardiology experts and comprehensive\nteleradiology services; and Nanox Health IT, which combines deep healthcare\nIT expertise with leading technology partners to deliver RIS, PACS, AI,\ndictation, and secure infrastructure solutions that streamline workflows and\nsupport safer, more efficient care delivery.\n\nBy integrating imaging technology, AI, cloud infrastructure, clinical\nexpertise, a marketplace, and health information technology, Nanox seeks to\nlower barriers to adoption, improve utilization, and advance preventive care\nworldwide. For more information, please visit www.nanox.vision.\n\nForward-Looking Statements\n\nThis press release may contain forward-looking statements that are subject to\nrisks and uncertainties. All statements that are not historical facts\ncontained in this press release are forward-looking statements. Such\nstatements include, but are not limited to, any statements relating to the\ninitiation, timing, progress and results of the Company’s research and\ndevelopment, manufacturing, and commercialization activities with respect to\nits X-ray source technology and the Nanox.ARC, the ability to realize the\nexpected benefits of its recent acquisitions and the projected business\nprospects of the Company and the acquired companies. In some cases, you can\nidentify forward-looking statements by terminology such as “can,”\n“might,” “believe,” “may,” “estimate,” “continue,”\n“anticipate,” “intend,” “should,” “plan,” “should,”\n“could,” “expect,” “predict,” “potential,” or the negative of\nthese terms or other similar expressions. Forward-looking statements are based\non information the Company has when those statements are made or\nmanagement’s good faith belief as of that time with respect to future\nevents and are subject to risks and uncertainties that could cause actual\nperformance or results to differ materially from those expressed in or\nsuggested by the forward-looking statements. Factors that could cause actual\nresults to differ materially from those currently anticipated include: risks\nrelated to (i) Nanox’s ability to complete development of the Nanox System;\n(ii) Nanox’s ability to successfully demonstrate the feasibility of its\ntechnology for commercial applications; (iii) Nanox’s expectations regarding\nthe necessity of, timing of filing for, and receipt and maintenance of,\nregulatory clearances or approvals regarding its technology, the Nanox.ARC and\nNanox.CLOUD from regulatory agencies worldwide and its ongoing compliance with\napplicable quality standards and regulatory requirements; (iv) Nanox’s\nability to realize the anticipated benefits of the acquisitions, which may be\naffected by, among other things, competition, brand recognition, the ability\nof the acquired companies to grow and manage growth profitably and retain\ntheir key employees; (v) Nanox’s ability to enter into and maintain\ncommercially reasonable arrangements with third-party manufacturers and\nsuppliers to manufacture the Nanox.ARC; (vi) the market acceptance of the\nNanox System and the proposed pay-per-scan business model; (vii) Nanox’s\nexpectations regarding collaborations with third-parties and their potential\nbenefits; (viii) Nanox’s ability to conduct business globally; (ix) changes\nin global, political, economic, business, competitive, market and regulatory\nforces; (x) risks related to the current war between Israel and Hamas and any\nworsening of the situation in Israel; (xi) risks related to business\ninterruptions resulting from the COVID-19 pandemic or similar public health\ncrises, among other things; and (xii) potential litigation associated with our\ntransactions.\n\nFor a discussion of other risks and uncertainties, and other important\nfactors, any of which could cause Nanox’s actual results to differ from\nthose contained in the Forward-Looking Statements, see the section titled\n“Risk Factors” in Nanox’s Annual Report on Form 20-F for the year ended\nDecember 31, 2024, and subsequent filings with the U.S. Securities and\nExchange Commission. The reader should not place undue reliance on any\nforward-looking statements included in this press release. Except as required\nby law, Nanox undertakes no obligation to update publicly any forward-looking\nstatements after the date of this press release to conform these statements to\nactual results or to changes in the Company’s expectations.\n\nContacts\n\nMedia Contact:\nBen Shannon\nICR Healthcare\nNanoxPR@icrinc.com\n\nInvestor Contact:\nMike Cavanaugh\nICR Healthcare\nmike.cavanaugh@icrhealthcare.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/7a1764f8-84e3-4b28-ae23-9add5d57c378)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNXbyq9YR-20260904","title":"Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England","author":"Globe Newswire","ticker":"NNOX","created":"2026-09-04T12:45:58.302Z","tickers":["NNOX"],"exchange":"NASDAQ","article_body":"Expands Nanox’s growing U.S. distribution network with a leading New\nEngland-based medical imaging provider\n\nPETACH TIKVA, Israel — September 4 2026 — Nano-X Imaging Ltd.\n(https://www.globenewswire.com/Tracker?data=D6dzEXnyZ1mc9pKURbmOrl5IbsuTD_iVXQnwi9y_NOl6DN3ic3vkP4dG0aqCF6CsZKl8CVGM1gm7z_Og7PMs_BHAXfWDJy0THVsHXRmWXBI=)\n(“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in innovative\nmedical imaging technology, today announced that its U.S.-based subsidiary,\nNanox Impact Inc., has entered into a distribution agreement with Associated\nX-Ray Imaging Corp., a New England-based provider of medical imaging equipment\nand services, specializing in X-ray, MRI, and CT systems, to support\ndeployment of the Nanox.ARC across the region.\n\nUnder the agreement, Associated X-Ray Imaging will market, distribute, and\nsupport the Nanox.ARC, an FDA-cleared, multisource 3D digital tomosynthesis\nsystem, leveraging its established regional presence and service\ninfrastructure across New England. The collaboration is expected to support\nNanox’s ongoing U.S. commercial execution by expanding access to advanced 3D\nimaging within additional outpatient and community-based clinical settings.\n\nAssociated X-Ray Imaging has been serving healthcare providers across New\nEngland for decades, supplying and servicing a broad range of diagnostic\nimaging technologies for hospitals, imaging centers, and specialty clinics.\n\n“We continue to build our U.S. commercial footprint through focused regional\ndistribution partnerships that are aligned with our deployment strategy,”\nsaid Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox.\n“Associated X-Ray Imaging brings long-standing customer relationships,\nstrong technical expertise, and a deep understanding of the New England\nimaging market. This partnership supports our efforts to expand measured\nadoption of the Nanox.ARC across additional clinical environments.”\n\n“We are pleased to partner with Nanox and add the Nanox.ARC to our imaging\nportfolio,” said John Olenio, Owner, Founder and Chief Executive Officer of\nAssociated X-Ray Imaging Corp. “We believe the Nanox.ARC offers a compelling\napproach to 3D imaging that aligns with our focus on providing practical\ndiagnostic solutions supported by reliable service across New England.”\n\nThis agreement represents another step in Nanox’s U.S. channel partner\nstrategy, as the Company continues to expand a diversified distribution\nnetwork to support commercial deployment of the Nanox.ARC across targeted U.S.\nregions.\n\nAbout Associated X-Ray Imaging Corp\n\nFounded in 1975, Associated X-Ray Imaging Corp. is a New England-based\nprovider of medical imaging equipment, service, and supplies. The company\nsupports hospitals, imaging centers, and specialty clinics with diagnostic\nimaging technologies across multiple modalities, including X-ray, MRI, and CT,\nsupported by a regional sales and service organization. For more information,\nvisit www.associatedxray.com\n\nAbout Nanox\n\nNanox (NASDAQ: NNOX) is focused on driving the world’s transition to\npreventive health care by delivering an integrated, end-to-end medical imaging\nand healthcare services platform.\n\nNanox combines affordable imaging hardware, advanced AI-based solutions,\ncloud-based software, access to remote radiology, health IT solutions, and a\nmarketplace to enable earlier detection, improved clinical efficiency, and\nbroader access to care.\n\nNanox’s vision is to expand the reach of medical imaging both within and\nbeyond traditional hospital settings by providing a seamless solution from\nscan to interpretation and beyond. By leveraging proprietary digital X-ray\ntechnology, AI-driven analytics, and a clinically driven approach, Nanox aims\nto enhance the efficiency of routine imaging workflows, support early\ndetection of disease, and improve patient outcomes.\n\nThe Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source\ndigital tomosynthesis imaging system designed for ease of use and\nscalability; Nanox.AI, a suite of AI-based algorithms that augment the\ninterpretation of routine CT imaging to identify early signs often associated\nwith chronic disease; Nanox.CLOUD, a cloud-based platform for secure data\nmanagement, storage, and advanced\nimaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide\naccess to remote radiology and cardiology experts and comprehensive\nteleradiology services; and Nanox Health IT, which combines deep healthcare\nIT expertise with leading technology partners to deliver RIS, PACS, AI,\ndictation, and secure infrastructure solutions that streamline workflows and\nsupport safer, more efficient care delivery.\n\nBy integrating imaging technology, AI, cloud infrastructure, clinical\nexpertise, a marketplace, and health information technology, Nanox seeks to\nlower barriers to adoption, improve utilization, and advance preventive care\nworldwide. For more information, please visit www.nanox.vision.\n\nForward-Looking Statements\n\nThis press release may contain forward-looking statements that are subject to\nrisks and uncertainties. All statements that are not historical facts\ncontained in this press release are forward-looking statements. Such\nstatements include, but are not limited to, any statements relating to the\ninitiation, timing, progress and results of the Company’s research and\ndevelopment, manufacturing, and commercialization activities with respect to\nits X-ray source technology and the Nanox.ARC, the ability to realize the\nexpected benefits of its recent acquisitions and the projected business\nprospects of the Company and the acquired companies. In some cases, you can\nidentify forward-looking statements by terminology such as “can,”\n“might,” “believe,” “may,” “estimate,” “continue,”\n“anticipate,” “intend,” “should,” “plan,” “should,”\n“could,” “expect,” “predict,” “potential,” or the negative of\nthese terms or other similar expressions. Forward-looking statements are based\non information the Company has when those statements are made or\nmanagement’s good faith belief as of that time with respect to future\nevents and are subject to risks and uncertainties that could cause actual\nperformance or results to differ materially from those expressed in or\nsuggested by the forward-looking statements. Factors that could cause actual\nresults to differ materially from those currently anticipated include: risks\nrelated to (i) Nanox’s ability to complete development of the Nanox System;\n(ii) Nanox’s ability to successfully demonstrate the feasibility of its\ntechnology for commercial applications; (iii) Nanox’s expectations regarding\nthe necessity of, timing of filing for, and receipt and maintenance of,\nregulatory clearances or approvals regarding its technology, the Nanox.ARC and\nNanox.CLOUD from regulatory agencies worldwide and its ongoing compliance with\napplicable quality standards and regulatory requirements; (iv) Nanox’s\nability to realize the anticipated benefits of the acquisitions, which may be\naffected by, among other things, competition, brand recognition, the ability\nof the acquired companies to grow and manage growth profitably and retain\ntheir key employees; (v) Nanox’s ability to enter into and maintain\ncommercially reasonable arrangements with third-party manufacturers and\nsuppliers to manufacture the Nanox.ARC; (vi) the market acceptance of the\nNanox System and the proposed pay-per-scan business model; (vii) Nanox’s\nexpectations regarding collaborations with third-parties and their potential\nbenefits; (viii) Nanox’s ability to conduct business globally; (ix) changes\nin global, political, economic, business, competitive, market and regulatory\nforces; (x) risks related to the current war between Israel and Hamas and any\nworsening of the situation in Israel; (xi) risks related to business\ninterruptions resulting from the COVID-19 pandemic or similar public health\ncrises, among other things; and (xii) potential litigation associated with our\ntransactions.\n\nFor a discussion of other risks and uncertainties, and other important\nfactors, any of which could cause Nanox’s actual results to differ from\nthose contained in the Forward-Looking Statements, see the section titled\n“Risk Factors” in Nanox’s Annual Report on Form 20-F for the year ended\nDecember 31, 2024, and subsequent filings with the U.S. Securities and\nExchange Commission. The reader should not place undue reliance on any\nforward-looking statements included in this press release. Except as required\nby law, Nanox undertakes no obligation to update publicly any forward-looking\nstatements after the date of this press release to conform these statements to\nactual results or to changes in the Company’s expectations.\n\nContacts\n\nMedia Contact:\nBen Shannon\nICR Healthcare\nNanoxPR@icrinc.com\n\nInvestor Contact:\nMike Cavanaugh\nICR Healthcare\nmike.cavanaugh@icrhealthcare.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/7a1764f8-84e3-4b28-ae23-9add5d57c378)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-09-04T12:45:58.347393072Z","server_sent_at_ms":1788525958347},"received_at":"2026-09-04T12:45:58.407Z","source_url":null},"analysis":{"id":"125009","press_release_id":"136129","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":["No financial terms, purchase commitments, or revenue expectations disclosed for the distribution agreement"],"eventType":"partnership","narrative":"Nanox's U.S. subsidiary Nanox Impact Inc. signed a distribution agreement with Associated X-Ray Imaging Corp. to market, distribute, and support the FDA-cleared Nanox.ARC multisource 3D digital tomosynthesis system across New England.\n\nAssociated X-Ray Imaging, founded in 1975, supplies and services X-ray, MRI, and CT systems for hospitals, imaging centers, and specialty clinics, giving Nanox an established regional sales and service channel in outpatient and community-based settings.\n\nNo financial terms, minimum volumes, or revenue targets were disclosed, and the agreement extends Nanox's existing regional channel-partner strategy rather than marking a new commercial phase.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Regional channel expansion for the Nanox.ARC is incremental commercial progress, but without disclosed terms there is little to anchor adoption expectations."},"keyFigures":{},"namedEntities":{"people":[{"name":"Erez Meltzer","role":"CEO and Acting Chairman of Nanox"},{"name":"John Olenio","role":"Owner, Founder and CEO of Associated X-Ray Imaging Corp."}],"products":["Nanox.ARC","Nanox.AI","Nanox.CLOUD","Nanox.MARKETPLACE","Nanox Health IT"],"companies":[{"name":"Nano-X Imaging Ltd.","ticker":"NNOX","relationship":"filer"},{"name":"Nanox Impact Inc.","relationship":"U.S.-based subsidiary of the filer and agreement signatory"},{"name":"Associated X-Ray Imaging Corp.","relationship":"distribution partner"},{"name":"USARAD Holdings","relationship":"subsidiary"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"A regional distribution agreement that incrementally expands Nanox.ARC channel coverage in New England, but with no disclosed financial terms, purchase commitments, or revenue expectations. It supports the existing U.S. channel strategy rather than changing the commercial trajectory."},"tickerRelevance":{"others":[],"primary":"NNOX"},"globalImportance":18,"audienceRelevance":25,"eventTypeSecondary":["operations_update"],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"regional distribution agreement with no disclosed financial terms","issuerAuthored":true,"commercialStage":"early U.S. commercial deployment","retailFavoriteBoost":"moderate - NNOX has a notable retail following"}},"event_type":"partnership","event_type_secondary":["operations_update"],"sentiment":"bullish","material_impact_score":2,"narrative":"Nanox's U.S. subsidiary Nanox Impact Inc. signed a distribution agreement with Associated X-Ray Imaging Corp. to market, distribute, and support the FDA-cleared Nanox.ARC multisource 3D digital tomosynthesis system across New England.\n\nAssociated X-Ray Imaging, founded in 1975, supplies and services X-ray, MRI, and CT systems for hospitals, imaging centers, and specialty clinics, giving Nanox an established regional sales and service channel in outpatient and community-based settings.\n\nNo financial terms, minimum volumes, or revenue targets were disclosed, and the agreement extends Nanox's existing regional channel-partner strategy rather than marking a new commercial phase.","key_figures":{},"named_entities":{"people":[{"name":"Erez Meltzer","role":"CEO and Acting Chairman of Nanox"},{"name":"John Olenio","role":"Owner, Founder and CEO of Associated X-Ray Imaging Corp."}],"products":["Nanox.ARC","Nanox.AI","Nanox.CLOUD","Nanox.MARKETPLACE","Nanox Health IT"],"companies":[{"name":"Nano-X Imaging Ltd.","ticker":"NNOX","relationship":"filer"},{"name":"Nanox Impact Inc.","relationship":"U.S.-based subsidiary of the filer and agreement signatory"},{"name":"Associated X-Ray Imaging Corp.","relationship":"distribution partner"},{"name":"USARAD Holdings","relationship":"subsidiary"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-04T12:47:10.734Z","global_importance":18,"audience_relevance":25,"importance_components":{"tickerTier":"small-cap","eventGravity":"regional distribution agreement with no disclosed financial terms","issuerAuthored":true,"commercialStage":"early U.S. commercial deployment","retailFavoriteBoost":"moderate - NNOX has a notable retail following"}},"durationMs":null,"modelName":"glm-4.7"}}